Around the world, thousands of high-containment labs work with dangerous pathogens, some with little oversight — and the pandemic prompted a global boom to build yet more. Perhaps nowhere are those tensions more apparent than in India, the world’s most populous nation and a global biotechnology powerhouse.
↧